The FDA sent warning letters to four companies making unsubstantiated claims about therapeutic benefits of their CBD products.
CIJ’s Brian Blumenfeld completes his series on federal reform proposals with a review of the cannabis banking and tax bills currently pending in Congress.
Does the recent bid for independence and subsequent political turmoil in Catalonia spell disaster for their cannabis industry?
The platform integrates payment processing and e-commerce with their compliance software.
A series of security breaches, website crashes and implementation delays have beleaguered the software company throughout 2017.
A number of setbacks, controversies and lawsuits keep the German cannabis market in limbo.
In the second part of this series, Roger Brauninger tells us about state regulations and their approach to laboratory accreditation.
Potency and homogeneity testing for medical concentrates and infused products will be required November 1st.
The state is taking a more public and educational approach to their outreach efforts.
The International Association of Cannabis Medicines brought some of the latest research and technology to Cologne.
